VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,852 | +1145.4% | 106,000 | +1225.0% | 0.02% | +1500.0% |
| Q4 2022 | $229 | -99.8% | 8,000 | +33.3% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | -11.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $164,000 | -50.3% | 6,000 | -30.2% | 0.00% | 0.0% |
| Q1 2022 | $330,000 | -99.1% | 8,600 | -99.3% | 0.00% | -99.3% |
| Q3 2021 | $38,575,000 | -13.3% | 1,308,953 | 0.0% | 0.14% | -11.7% |
| Q2 2021 | $44,478,000 | -24.6% | 1,308,953 | -27.9% | 0.16% | -34.5% |
| Q1 2021 | $59,007,000 | -13.5% | 1,815,599 | -4.1% | 0.25% | -17.0% |
| Q4 2020 | $68,195,000 | +12.0% | 1,893,242 | +21.8% | 0.30% | -1.0% |
| Q3 2020 | $60,884,000 | +25.9% | 1,554,742 | +17.9% | 0.30% | +17.4% |
| Q2 2020 | $48,358,000 | – | 1,318,377 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |